Draganfly (DPRO) Earnings Analysis
Draganfly (DPRO) has no confirmed upcoming earnings date. Last quarter (2026-05-11) it missed with EPS -0.12 USD vs -0.1 USD est (-20%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -4.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DPRO next report earnings?
No confirmed upcoming earnings date is currently scheduled for DPRO. This page updates as the calendar is published.
DPRO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.12 USD | -0.1 USD | -20% | Miss |
| 2026-03-24 | -0.2 USD | -0.13472 USD | -48.5% | Miss |
| 2025-11-12 | -0.18 USD | -0.19 USD | +5.3% | Beat |
| 2025-08-11 | -0.44 USD | -0.46 USD | +4.3% | Beat |
| 2025-05-08 | -0.44 USD | -0.48 USD | +8.3% | Beat |
| 2024-11-14 | -0.82 USD | -1.01 USD | +18.8% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
DPRO valuation and analyst view
| Trailing P/E | -4.47 |
|---|---|
| Trailing EPS | -0.77801 USD |
| Price / book | 1.26 |
| Dividend yield | 0.00% |
| Market cap | 0.10B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 13 USD |
Related research pages
Frequently asked questions
When is Draganfly (DPRO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for DPRO. This page updates as the calendar is published.
Did DPRO beat earnings last quarter?
In its 2026-05-11 report, DPRO posted EPS of -0.12 USD versus a -0.1 USD estimate — a miss of 20%.
What is DPRO's earnings track record?
Over the last 6 reported quarters with consensus data, DPRO beat estimates 4 times (67%).
What is DPRO's current P/E ratio and EPS?
DPRO trades at a trailing P/E of -4.47 on trailing EPS of -0.7780098667306494 USD.
What do analysts rate DPRO?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 13 USD.